Both in Pharmaceuticals
CAMP4 Therapeutics vs Akebia Therapeutics
Over the past year CAMP returned +27.4% and AKBA returned −67.3%; their daily moves had a correlation of 0.15.
CAMP +27.4% AKBA −67.3%Growth of $1, one year, split-adjusted
| Metric | CAMP | AKBA |
|---|---|---|
| Price | $3.91 | $0.8861 |
| Market cap | $245.4M | $245.5M |
| Today | +1.56% | −0.78% |
| 1 month | −5.8% | +0.9% |
| 6 months | −2.3% | −32.9% |
| Year to date | −36.2% | −45.0% |
| 1 year | +31.2% | −67.7% |
| Revenue growth (YoY) | +18.8% | −21.4% |
| Gross margin | 100.0% | 78.8% |
| Net margin | −1884.8% | −18.1% |
| P/E (TTM) | — | — |
| Price / sales | 58.2× | 1.1× |
| Net cash | $86.4M | $106.0M |
| Dividend yield | — | — |
| Volatility (60d) | 97.1% | 81.8% |
| Short % of float | 3.4% | 7.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).